Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Financial Crisis 2008: Is the Story Going to Repeat?

The coming year has the potential for a combination of major risks to the global economy coming together to cause a financial crisis rivaling that of 2008-09. The mortgage bubble that burst in 2008 led to multiple failures of financial institutions, major downturns in global...
Carl Cotton | March 15, 2019 |

Gold and Lagarde – Friends or Foes?

A week ago, Lagarde chaired the monetary policy meeting of the Governing Council of the ECB for the first time. An insightful press conference followed in the footsteps. What will her presidency imply for the ECB’s policy and the gold market precisely? Key T...
Arkadiusz Sieron | December 20, 2019 |

Investment opportunities in America's energy pipeline needs

The Keystone XL ruckus shone a light on pipelines like never before. From the heated nature of the debate one could be forgiven for thinking that long, high-volume pipelines are something new to America. Really, that couldn't be further from the truth: The United States bu...
Marin Katusa | October 28, 2012 |

Buzz on the Bullboards: Biggest Last-Minute Moves of 2020

(Image via Kontrol Energy Corp.) Many investors may have anticipated a relaxed market heading into the holidays to cap off a tumultuous 2020 for the record books, yet 2020 continues to surprise us as we see engagement and announcements stay steady across the board ...
Stockhouse Editorial | December 8, 2020 |

Profiting from Europe's new gold rush

Europe owns a sizable chunk of the world's natural resources. Over the past few decades, however, EU countries have mostly imported their resources. Outlandish? Maybe. But it was simply easier, cheaper, and most importantly it avoided most environmental conflicts. Ge...
Jeff Clark, Casey Research | October 28, 2012 |

Price Target Raised on Biopharma Ahead of Leukemia Trial Update

The expected data and their implications were addressed in a ROTH Capital Partners report. In an April 29 research report, analyst Jotin Marango reported that ROTH Capital Partners raised its price target on ArQule Inc. (ARQL:NASDAQ) to $10 per share in an...
Streetwise Reports | May 9, 2019 |

Target Raised on Explorer; Val d'Or Project Is 'Gift That Keeps on Giving

The latest drill results are delivered and interpreted in an iA Securities report. In an Aug. 1 research note, analyst George Topping reported that iA Securities raised its target price on Wesdome Gold Mines Ltd. (WDO:TSX) to CA$7.50 per share from CA$7 bec...
Streetwise Reports | August 9, 2019 |

Target Price Raised on 'One of the Highest-Quality Stories' in Oil & Gas

The changes made and the reasons for them are detailed in a Raymond James report. In an Oct. 8 research note, analyst Justin Jenkins reported that Raymond James raised its target price on Phillips 66 (PSX:NYSE) to $120 per share from $117 "on higher conviction in ea...
Streetwise Reports | October 10, 2019 |

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
Streetwise Reports | November 7, 2019 |

Horizon Therapeutics Shares Rise 15% on Strong Q1 Results and Raised F/Y Sales Guidance

Shares of Horizon Therapeutics traded higher setting a new 52-week high price after the company reported a 27% y-o-y increase in net sales for Q1/20 and raised FY/20 net sales guidance. Biopharmaceutical company Horizon Therapeutics Inc. (HZNP:NASDAQ) , whi...
Streetwise Reports | May 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...